XML 33 R12.htm IDEA: XBRL DOCUMENT
v3.25.2

Goodwill and Other Intangible Assets | 12 Months Ended
--- | ---
Jun. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract] |
Goodwill and Other Intangible Assets | 5. Goodwill and Other Intangible Assets Goodwill The following table summarizes the changes in the carrying amount of goodwill for the two reportable segments and the remaining operating segments, included in Other and in total:
(in millions) | Pharmaceutical and Specialty Solutions |  | Global Medical Products and Distribution (1) |  | Other (2) (3) |  | Total
Balance at June 30, 2023 | $ | 2,762 |  |  | $ | 681 |  |  | $ | 1,170 |  |  | $ | 4,613 |
Goodwill acquired, net of purchase price adjustments | 793 |  |  | (3) |  |  | — |  |  | 790 |
Foreign currency translation adjustments and other | — |  |  | (3) |  |  | — |  |  | (3) |
Goodwill Impairment | — |  |  | (675) |  |  | — |  |  | (675) |
Balance at June 30, 2024 | $ | 3,555 |  |  | $ | — |  |  | $ | 1,170 |  |  | $ | 4,725 |
Goodwill acquired, net of purchase price adjustments | 4,389 |  |  | — |  |  | 578 |  |  | 4,967 |
Foreign currency translation adjustments and other | (1) |  |  | — |  |  | — |  |  | (1) |
Balance at June 30, 2025 | $ | 7,943 |  |  | $ | — |  |  | $ | 1,748 |  |  | $ | 9,691 |
(1) At June 30, 2025 and 2024, the GMPD segment accumulated goodwill impairment loss was $5.4 billion. (2) At June 30, 2025 and 2024, the Nuclear and Precision Health Solutions accumulated goodwill impairment loss was $829 million. (3) Comprised of the remaining operating segments, Nuclear and Precision Health Solutions, at-Home Solutions, and OptiFreight® Logistics. The increase in the Pharma segment goodwill is primarily due to the GIA and ION acquisitions that occurred during fiscal 2025. The increase in the Other segment goodwill is due to the ADS acquisition that occurred during fiscal 2025. Goodwill recognized in connection with these acquisitions primarily represent the expected benefits from the expected growth from new customers, the assembled workforce of the acquired entities, and synergies of integrating these businesses. Substantially all of the goodwill recorded is expected to be nondeductible for income tax purposes. During fiscal 2025, we did not identify any indicators of impairment within our reporting units. We performed interim quantitative goodwill impairment testing for GMPD at September 30, 2023 and March 31, 2024, which resulted in pre-tax goodwill impairment charges of $585 million and $90 million, respectively. GMPD goodwill was fully impaired during the third quarter of fiscal 2024. During fiscal 2023, GMPD had cumulative pre-tax impairment charges of $1.2 billion. These goodwill impairment charges are recorded in impairments and (gain)/loss on disposal of assets, net in our consolidated statements of earnings. In connection with the divestiture of the Outcomes business, during fiscal 2023, we allocated and reclassified $24 million of goodwill from the Pharma operating segment to the Outcomes disposal group based on the estimated relative fair values of the business to be disposed of and the portion of the reporting unit that was retained. Other Intangible Assets The following tables summarize other intangible assets by class at June 30:
| 2025
(in millions) | Gross Intangible |  | Accumulated Amortization |  | Net Intangible |  | Weighted- Average Remaining Amortization Period (Years)
Indefinite-life intangibles: |  |  |  |  |  |  |
Trademarks and patents | $ | 13 |  |  | $ | — |  |  | $ | 13 |  |  | N/A
Total indefinite-life intangibles | 13 |  |  | — |  |  | 13 |  |  | N/A
Definite-life intangibles: |  |  |  |  |  |  |
Customer intangibles | 3,876 |  |  | 2,639 |  |  | 1,237 |  |  | 11
Trademarks, trade names, and patents | 1,340 |  |  | 459 |  |  | 881 |  |  | 8
Developed technology and other | 1,030 |  |  | 726 |  |  | 304 |  |  | 6
Non-Competition Agreements | 72 |  |  | 21 |  |  | 51 |  |  | 4
Total definite-life intangibles | 6,318 |  |  | 3,845 |  |  | 2,473 |  |  | 10
Total other intangible assets | $ | 6,331 |  |  | $ | 3,845 |  |  | $ | 2,486 |  |  | N/A
| 2024
(in millions) | Gross Intangible |  | Accumulated Amortization |  | Net Intangible
Indefinite-life intangibles: |  |  |  |  |
Trademarks and patents | $ | 12 |  |  | $ | — |  |  | $ | 12 |
Total indefinite-life intangibles | 12 |  |  | — |  |  | 12 |
Definite-life intangibles: |  |  |  |  |
Customer intangibles | 3,628 |  |  | 2,431 |  |  | 1,197 |
Trademarks, trade names, and patents | 561 |  |  | 408 |  |  | 153 |
Developed technology and other | 1,047 |  |  | 684 |  |  | 363 |
Total definite-life intangibles | 5,236 |  |  | 3,523 |  |  | 1,713 |
Total other intangible assets | $ | 5,248 |  |  | $ | 3,523 |  |  | $ | 1,725 |
The increase in definite-life intangibles is primarily due to the ADS, GIA, and ION acquisitions. Total amortization of intangible assets was $303 million, $264 million, and $281 million for fiscal 2025, 2024, and 2023, respectively. The estimated annual amortization for intangible assets for fiscal 2026 through 2030 is as follows: $360 million, $364 million, $330 million, $307 million, and $284 million.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-30/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-20/tableOfContent + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration